Search - tctmd.com

Displaying 381 - 400 of 2554

Sort: Relevancy | Date

BIOFLOW V: Orsiro Still Offers Some Benefits at 5 Years

News Conference News

BIOFLOW V: Orsiro Still Offers Some Benefits at 5 Years

March 02, 2022

Longer-Term LRT Results ‘Encouraging’ for TAVI in Low-risk Patients

News Conference News

Longer-Term LRT Results ‘Encouraging’ for TAVI in Low-risk Patients

March 01, 2022

March 2022 News Roundup

News Opinion CV Team Dispatch

March 2022 News Roundup

March 01, 2022

Two Large Studies Affirm Rare Thrombosis Risk With ChAdOx1 COVID-19 Vax

News Daily News

Two Large Studies Affirm Rare Thrombosis Risk With ChAdOx1 COVID-19 Vax

Michael O'Riordan

February 23, 2022

Ischemic Stroke Risk Highest Early After COVID-19 Diagnosis

News Conference News ISC 2022

Ischemic Stroke Risk Highest Early After COVID-19 Diagnosis

February 17, 2022

Even Less-Severe COVID-19 Can Have Long-term CV Effects

News Daily News

Even Less-Severe COVID-19 Can Have Long-term CV Effects

February 10, 2022

ACTION-CVT: DOACs Look Like a Good Option for Cerebral Venous Thrombosis

News Conference News ISC 2022

ACTION-CVT: DOACs Look Like a Good Option for Cerebral Venous Thrombosis

February 10, 2022

Heart Failure, Hope, and the Hurdles Ahead for Xenotransplantation

News Opinion Off Script

Heart Failure, Hope, and the Hurdles Ahead for Xenotransplantation

Charles C. Hong, MD, PhD

February 04, 2022

Myocarditis After COVID Vaccination Is Rare, Resolves Quickly, Studies Confirm

News Daily News

Myocarditis After COVID Vaccination Is Rare, Resolves Quickly, Studies Confirm

January 25, 2022

DOACs Should Be Standard to Prevent VTE Recurrence in Cancer: Meta-analysis

News Daily News

DOACs Should Be Standard to Prevent VTE Recurrence in Cancer: Meta-analysis

January 20, 2022

COVID-19: TCTMD’s Dispatch for January Week 3

News Daily News

COVID-19: TCTMD’s Dispatch for January Week 3

January 17, 2022

Hearts, Lungs, Kidneys: Mild-to-Moderate COVID-19 Leaves a Mark

News Daily News

Hearts, Lungs, Kidneys: Mild-to-Moderate COVID-19 Leaves a Mark

January 14, 2022

Shorter Anticoagulation an Option for Young Patients With Provoked VTE

News Daily News

Shorter Anticoagulation an Option for Young Patients With Provoked VTE

January 11, 2022

COVID-19: TCTMD’s Dispatch for January Week 2

News Daily News

COVID-19: TCTMD’s Dispatch for January Week 2

January 10, 2022

Statins No Benefit to ICU-Admitted COVID-19 Patients: INSPIRATION-S

News Daily News

Statins No Benefit to ICU-Admitted COVID-19 Patients: INSPIRATION-S

January 07, 2022

COVID-19: TCTMD’s Dispatch for January Week 1

News Daily News

COVID-19: TCTMD’s Dispatch for January Week 1

January 03, 2022

January 2022 News Roundup

News Opinion CV Team Dispatch

January 2022 News Roundup

January 01, 2022

The Biggest News of 2021: TCTMD’s Top 10

News Opinion Editor's Corner

The Biggest News of 2021: TCTMD’s Top 10

December 30, 2021

MICHELLE Published: Low-Dose Rivaroxaban Cuts VTE Risk After COVID-19 Admission

News Daily News

MICHELLE Published: Low-Dose Rivaroxaban Cuts VTE Risk After COVID-19 Admission

December 29, 2021

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

News Daily News

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

December 28, 2021

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.